What do you do when a 100+ page evidence-rich guideline drops?Most of us intend to read it, save it for later… and never really use it effectively. Not because we do not care, but because we were never taught how to read them.In t...

Let’s talk about statins. I know… boring, right? Most of us already know a lot about them. But thinking of statins only as cholesterol drugs misses the bigger picture.In many ways, statins are best understood as anti-atherosclerotic t...

In this special LipidCurious Inspiration episode, Dr. Vishnu Priya Pulipati, MD, FACE, DiplABCL, sits down with legendary lipid educator Dr. Thomas Dayspring, MD, FACP, FNLA, for a conversation beyond guidelines and numbers. Toget...

Note: This episode reflects pre-2026 dyslipidemia guidelines. Some recommendations may no longer align with current guidelines. ASCVD prevention isn’t about numbers; it’s about extending healthy years.  Treat the right i...

Note: This episode reflects pre-2026 dyslipidemia guidelines. Some recommendations may no longer align with current guidelines. ASCVD risk stratification gets messy fast—especially when calculators, risk enhancers, and corona...